Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
9.18 USD
0.88%
Market Closed
Updated:
Apr 27, 2024
Phathom Pharmaceuticals Inc
Cash from Investing Activities
|
Phathom Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Cash from Investing Activities
-$1.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-15%
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Phathom Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.6m
USD
-1.6m
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Cash from Investing Activities amounts to -1.6m USD.
What is Phathom Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-16%
-16%
Over the last year, the Cash from Investing Activities growth was -57%. The average annual Cash from Investing Activities growth rates for Phathom Pharmaceuticals Inc have been -16% over the past three years .
You don't have any saved screeners yet
